See All News - tctmd.com

News

News Conference News ESC 2017

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

Shelley Wood

September 01, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Conference News ESC 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Michael O'Riordan

August 31, 2017

News Daily News

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Yael L. Maxwell

August 31, 2017

News Industry News

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

August 26, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Opinion Fellow Talk

Cost Awareness and Fellowship Education

Amit K. Gupta, MBBS, MD

August 31, 2017

News Conference News ESC 2017

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Shelley Wood

August 30, 2017

News Conference News ESC 2017

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

Michael O'Riordan

August 30, 2017

News Industry News

iVascular & Braile partner to develop structural heart solutions

June 19, 2017

Advertisement

News

Fentanyl, Ubiquitous in US Cath Labs, Blunts Antiplatelet Drugs in PCI

TCTMD’s Top 10 Most Popular Stories for August 2017

Nonagenarians Fare Well After TAVR, Once They Get Beyond 30 Days

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Study Results: Titaniam-nitride-oxide (TiNO) Coated Stent is Non-inferior to Bioabsorbable Polymer Everolimus-eluting Stent (EES), for Patients Presenting with Acute Coronary Syndrome (ACS)

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Cost Awareness and Fellowship Education

BIOFLOW V: ‘Ultrathin-Strut’ Stent Beats Out Xience at 12 Months

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

iVascular & Braile partner to develop structural heart solutions

Search News

Advertisement

Advertisement

News

Search News

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content